Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)
CNY 17.07
(1.01%)
CNY 17.07
(1.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 209.5 Million | 331.38 Million | 196.33 Million | 76.37 Million | 268.32 Million | 162.68 Million |
| Net Income | 361.82 Million | 93.6 Million | 122.1 Million | 8.61 Million | 188.13 Million | 184.97 Million |
| Depreciation & Amortization | 67.3 Million | 66.12 Million | 60.2 Million | 63.47 Million | 60.77 Million | 54.79 Million |
| Deferred income taxes | -5.47 Million | -15.35 Million | -8.74 Million | 1.39 Million | -4.32 Million | -212.7 Thousand |
| Stock-based compensation | 6.11 Million | 414.36 Thousand | - | - | - | - |
| Change in working capital | 1.63 Million | 137.86 Million | 17.62 Million | -51.18 Million | 21.16 Million | -54.58 Million |
| Other non-cash items | -79.33 Million | 33.79 Million | -3.59 Million | 55.45 Million | -1.75 Million | -22.49 Million |
| Investing Cash Flow | 9.85 Million | -155.64 Million | -76.11 Million | -92.91 Million | -66.04 Million | -63.87 Million |
| Investments in PPE | -61.71 Million | -40.91 Million | -88.23 Million | -100.66 Million | -90.45 Million | -104.42 Million |
| Acquisitions | 151.53 Million | 115.27 Million | 85.16 Thousand | 100.78 Million | 135.26 Thousand | - |
| Investment purchases | -470 Million | -320.04 Million | -70 Million | -750 Thousand | -135.26 Thousand | -700 Million |
| Sales/Maturities of investments | 390.04 Million | 90.03 Million | 82.03 Million | 8.38 Million | 24.27 Million | 739.07 Million |
| Other Investing Activities | -1.00 | 0.78 | 0.81 | -100.66 Million | 135.26 Thousand | 1.47 Million |
| Financing Cash Flow | -48.82 Million | -33.78 Million | -18.24 Million | -75.05 Million | -65.89 Million | -92.28 Million |
| Debt repayment | -300 Thousand | -58.49 Thousand | - | -40 Million | -30 Million | -55 Million |
| Dividends payments | -54.73 Million | -54.73 Million | -18.24 Million | -54.73 Million | -54.73 Million | -57.28 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5.91 Million | 21 Million | - | 20 Million | 19.99 Million | 20 Million |
| Accounts receivables | 17.52 Million | 25.12 Million | -19.49 Million | -4.28 Million | -44.93 Million | -205.68 Million |
| Accounts payables | -28.27 Million | 116.95 Million | 50.21 Million | -78.15 Million | 74.31 Million | 170.81 Million |
| Inventory | 8.9 Million | 11.14 Million | -4.35 Million | 29.86 Million | -3.88 Million | -19.5 Million |
| Other working capital | 3.49 Million | -15.35 Million | -8.74 Million | 1.39 Million | -4.32 Million | -35.08 Million |
| Cash at beginning of period | 1.79 Billion | 1.62 Billion | 1.52 Billion | 1.61 Billion | 1.48 Billion | 1.47 Billion |
| Cash at end of period | 1.98 Billion | 1.76 Billion | 1.62 Billion | 1.52 Billion | 1.61 Billion | 1.48 Billion |
| Capital Expenditure | -61.71 Million | -40.91 Million | -88.23 Million | -100.66 Million | -90.45 Million | -104.42 Million |
| Effect of forex changes on cash | 25.13 Million | - | - | 0.49 | 0.19 | 82.67 Thousand |
| Net cash flow / Change in cash | 195.67 Million | 141.95 Million | 101.97 Million | -91.6 Million | 136.37 Million | 6.6 Million |
| Free Cash Flow | 147.78 Million | 290.46 Million | 108.09 Million | -24.29 Million | 177.86 Million | 58.25 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 66.89 Million | 43.19 Million | 59.15 Million | 19.16 Million | 361.82 Million | 252.48 Million |
| Depreciation & Amortization | - | 19.78 Million | 19.78 Million | 16.63 Million | 67.3 Million | -33.67 Million |
| Deferred income taxes | - | - | - | -36.02 Million | -5.47 Million | -56.79 Million |
| Stock-based compensation | - | 3.32 Million | - | 6.11 Million | 6.11 Million | -2.85 Million |
| Change in working capital | - | -135.51 Million | - | 29.91 Million | 1.63 Million | 93.33 Million |
| Other non-cash items | -9.22 Million | -18.23 Million | 34.39 Million | 82.98 Million | -79.33 Million | -261.75 Million |
| Investing Cash Flow | -28.33 Million | -380.49 Million | -16.09 Million | -300.74 Million | 9.85 Million | 273.29 Million |
| Investments in PPE | -8.4 Million | -11.17 Million | -11.15 Million | -13.66 Million | -61.71 Million | -4.81 Million |
| Acquisitions | 95.51 Thousand | - | 24.51 Thousand | -101.73 Million | 151.53 Million | 247.9 Million |
| Investment purchases | -965 Million | -470 Million | -180 Million | -310 Million | -470 Million | 30 Million |
| Sales/Maturities of investments | 943.97 Million | 100.74 Million | 140.93 Million | 119.65 Million | 390.04 Million | 2.84 Million |
| Other Investing Activities | 1 Million | -60.24 Thousand | 34.1 Million | 5 Million | -1.00 | -2.63 Million |
| Financing Cash Flow | -58.18 Million | 18.18 Million | -94.21 Million | 6.93 Million | -48.82 Million | -66.38 Thousand |
| Debt repayment | -115.27 Thousand | -1.79 Million | -22.45 Million | - | -300 Thousand | - |
| Dividends payments | - | -49.72 Million | -5.2 Million | -54.73 Million | -54.73 Million | -66.38 Thousand |
| Common Stock Repurchased | 444.42 Thousand | -444.42 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -58.51 Million | 16.84 Million | -71.76 Million | 61.66 Million | 5.91 Million | -66.38 Thousand |
| Accounts receivables | - | -87.91 Million | - | 17.52 Million | 17.52 Million | 85.81 Million |
| Accounts payables | - | - | - | - | -28.27 Million | - |
| Inventory | - | -47.6 Million | - | 8.9 Million | 8.9 Million | 7.51 Million |
| Other working capital | - | - | - | 3.49 Million | 3.49 Million | - |
| Cash at beginning of period | 1.59 Billion | 1.95 Billion | 1.98 Billion | 2.12 Billion | 1.79 Billion | 1.85 Billion |
| Cash at end of period | 1.55 Billion | 1.59 Billion | 1.95 Billion | 1.98 Billion | 1.98 Billion | 2.11 Billion |
| Capital Expenditure | -8.4 Million | -11.17 Million | -11.15 Million | -13.66 Million | -61.71 Million | -4.81 Million |
| Effect of forex changes on cash | - | - | - | 39.12 Million | 25.13 Million | -2.84 Million |
| Net cash flow / Change in cash | -39.01 Million | -355.04 Million | -36.38 Million | -135.9 Million | 195.67 Million | 261.11 Million |
| Free Cash Flow | 49.26 Million | -5.99 Million | 82.38 Million | 105.11 Million | 147.78 Million | -14.08 Million |
CRZBY
MRC
6MK
2345
YCP
TAM